Skip to main content
SpringerLink
Log in

THE NK/DC COMPLOT

  • Chapter
  • First Online:
Crossroads between Innate and Adaptive Immunity II

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 633))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cooper, M.A., Fehniger, T.A. Caligiuri, M.A. (2001)The biology of human natural killer-cell subsets. Trends Immunol 22, 633–640

    Article  Google Scholar 

  2. Moretta, A. et al. (2005)Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol 26, 668–675

    Article  CAS  Google Scholar 

  3. Mailliard, R.B. et al. (2005)IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med 202, 941–953

    Article  CAS  Google Scholar 

  4. Marcenaro, E. et al. (2005)IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors. J Immunol 174, 3992–3998

    Google Scholar 

  5. Moretta, A. (2002)Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2, 957–964

    Article  CAS  Google Scholar 

  6. Martin-Fontecha, A. et al. (2004)Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5, 1260–1265

    Article  CAS  Google Scholar 

  7. Moretta, A., Bottino, C., Mingari, M.C., Biassoni, R. Moretta, L. (2002)What is a natural killer cell? , Nat Immunol36–8

    Article  PubMed  CAS  Google Scholar 

  8. Ljunggren, H.G. Karre, K. (1990)In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 11, 237–244

    Article  Google Scholar 

  9. Moretta, A. et al. (1996)Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 14, 619–648

    Article  Google Scholar 

  10. Long, E.O. (1999)Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 17, 875–904

    Article  Google Scholar 

  11. Lopez-Botet, M., Llano, M., Navarro, F. Bellon, T. (2000)NK cell recognition of non-classical HLA class I molecules. Semin Immunol 12, 109–119

    Article  CAS  Google Scholar 

  12. Vilches, C. Parham, P. (2002)KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 20, 217–251

    Article  Google Scholar 

  13. Moretta, A. et al. (2001)Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19, 197–223

    Article  Google Scholar 

  14. Vivier, E., Nunes, J.A. Vely, F. (2004)Natural killer cell signaling pathways. Science 306, 1517–1519

    Article  Google Scholar 

  15. Bryceson, Y.T., March, M.E., Barber, D.F., Ljunggren, H.G. Long, E.O. (2005)Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 202, 1001–1012

    Article  CAS  Google Scholar 

  16. Bryceson, Y.T., March, M.E., Ljunggren, H.G. Long, E.O. (2006)Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 214, 73–91

    Article  Google Scholar 

  17. Bryceson, Y.T., March, M.E., Ljunggren, H.G. Long, E.O. (2006)Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107, 159–166

    Article  CAS  Google Scholar 

  18. Moretta, A., Biassoni, R., Bottino, C., Mingari, M.C. Moretta, L. (2000)Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol Today 21, 228–234

    Article  Google Scholar 

  19. Moretta, A., Marcenaro, E., Parolini, S., Ferlazzo, G. Moretta, L. NK cells at the interface between innate and adaptive immunity. Cell Death Differ (2007)<bib id="bib192_"> <no>19.</no> <otherref>Moretta, A., Marcenaro, E., Parolini, S., Ferlazzo, G. &#x0026; Moretta, L. NK cells at the interface between innate and adaptive immunity. <Emphasis Type="Italic">Cell Death Differ</Emphasis> (2007)</otherref> </bib>

    Google Scholar 

  20. Campbell, J.J. et al. (2001)Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 166, 6477–6482

    Google Scholar 

  21. Robertson, M.J. (2002)Role of chemokines in the biology of natural killer cells. J Leukocyte Biol, 71173–183

    CAS  Google Scholar 

  22. Parolini, S. et al. (2007)The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109, 3625–3632

    Article  CAS  Google Scholar 

  23. Vitale, M. et al. (2004)The small subset of CD56brightCD16− natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol 34, 1715–1722

    Article  CAS  Google Scholar 

  24. Kawashima, D. et al. (2005)Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn’s disease. J Clin Pathol 58, 1057–1063

    Article  CAS  Google Scholar 

  25. Ngo, V.N., Tang, H.L. Cyster, J.G. (1998)Epstein–Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med, 188181–191

    Article  CAS  Google Scholar 

  26. Ferlazzo, G. et al. (2004)The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 172, 1455–1462

    Google Scholar 

  27. Fehniger, T.A. et al. (2003)CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101, 3052–3057

    Article  CAS  Google Scholar 

  28. Romagnani, C. et al. (2007)CD56brightCD16− killer Ig-like receptor – NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 178, 4947–4955

    Google Scholar 

  29. Sivori, S. et al. (2004)CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101, 10116–10121

    Article  Google Scholar 

  30. Della Chiesa, M., Romagnani, C., Thiel, A., Moretta, L. Moretta, A. (2006)Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood 108, 3851–3858

    Article  CAS  Google Scholar 

  31. Della Chiesa, M. et al. (2003)The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 33, 1657–1666

    Article  CAS  Google Scholar 

  32. Mailliard, R.B. et al. (2003)Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 171, 2366–2373

    Google Scholar 

  33. Mocikat, R. et al. (2003)Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 19, 561–569

    Article  Google Scholar 

  34. Lucas, M., Schachterle, W., Oberle, K., Aichele, P. Diefenbach, A. (2007)Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26, 503–517

    Article  CAS  Google Scholar 

  35. Dao, T. et al. (2005)Natural killer cells license dendritic cell cross-presentation of B lymphoma cell-associated antigens. Clin Cancer Res 11, 8763–8772

    Article  Google Scholar 

  36. Hanna, J. Mandelboim, O. (2007)When killers become helpers. Trends Immunol 28, 201–206

    Article  CAS  Google Scholar 

  37. Hanna, J. et al. (2005)Proteomic analysis of human natural killer cells: insights on new potential NK immune functions. Mol Immunol, 42425–431

    Article  CAS  Google Scholar 

  38. Zingoni, A. et al. (2004)Cross-talk between activated human NK cells and CD4+ T cells via OX40–OX40 ligand interactions. J Immunol 173, 3716–3724

    Google Scholar 

  39. Hanna, J. et al. (2004)Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 114, 1612–1623

    Google Scholar 

  40. Hanna, J. et al. (2004)Novel insights on human NK cells’ immunological modalities revealed by gene expression profiling. J Immunol 173, 6547–6563

    Google Scholar 

  41. Taieb, J. et al. (2006)A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med 12, 214–219

    Article  CAS  Google Scholar 

  42. Chan, C.W. et al. (2006)Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med 12, 207–213

    Article  CAS  Google Scholar 

  43. Blasius, A.L., Barchet, W., Cella, M. Colonna, M. (2007)Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells. J Exp Med 204, 2561–2568

    Article  CAS  Google Scholar 

  44. Vosshenrich, C.A. et al. (2007)CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J Exp Med 204, 2569–2578

    Article  CAS  Google Scholar 

  45. Caminschi, I. et al. (2007)Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J Exp Med 204, 2579–2590

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants awarded by Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.), Istituto Superiore di Sanità (I.S.S.), Ministero della Salute – RF 2002/149, Ministero dell’Istruzione dell’Università e della Ricerca (M.I.U.R.), FIRB-MIUR progetto-cod.RBNE017B4C, Ministero dell’Università e della Ricerca Scientifica e Tecnologica (M.U.R.S.T.), European Union FP6, LSHB-CT-2004-503319-Allostem, and Compagnia di San Paolo.

Author information

Authors and Affiliations

  1. Dipartimento di Medicina Sperimentale, Sezione di Istologia, Università degli Studi di Genova, Via G.B. Marsano, 10, 16132, Genova, Italy

    Emanuela Marcenaro

Authors
  1. Emanuela Marcenaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mariella Della Chiesa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Silvia Pesce
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sophie Agaugué
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alessandro Moretta
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Immunology, La Jolla Institute for Allergy &, Science Center Drive 10355 , San Diego, 92121, U.S.A.

    Stephen P. Schoenberger

  2. College of Medicine, Drexel University, Queen Lane 2900, Philadelphia, 19129, U.S.A.

    Peter D. Katsikis

  3. Emory Vaccine Center &, Emory University, Gatewood Rd. 954, Atlanta, 30329, U.S.A.

    Bali Pulendran

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Marcenaro, E., Chiesa, M., Pesce, S., Agaugué, S., Moretta, A. (2009). THE NK/DC COMPLOT. In: Schoenberger, S., Katsikis, P., Pulendran, B. (eds) Crossroads between Innate and Adaptive Immunity II. Advances in Experimental Medicine and Biology, vol 633. Springer, New York, NY. https://doi.org/10.1007/978-0-387-79311-5_2

Download citation

Publish with us

Policies and ethics

Search

Navigation